Amundi S&P Global Health Care ESG UCITS ETF DR EUR (A)
S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care
- ISIN
- IE0006FM6MI8
- Issuer
- Amundi ETF
- TER
- 0.18%
- Latest closing price
- N/A
- Fund Size
- €542 m As of: Sep 30, 2026
- Domicile
- Ireland
- Distribution Policy
- Accumulating
- Replication Method
- Physical
- Base Currency
- EUR
- WKN / Ticker
- A3DSTC / WELS
Data availability
Data is available for 2 of 5 areas for this fund.
- Master data (TER, index, size): As of: Sep 30, 2026
- Closing price: not available
- Price history (at least 20 prices): not available
- Holdings: As of: Jul 23, 2026
- Risk figures: not available
Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.
At a glance
Amundi S&P Global Health Care ESG UCITS ETF DR EUR (A) (ISIN IE0006FM6MI8) is a fund from Amundi ETF (fund type: ETF). Benchmark index: S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care. Its ongoing charges (TER) are 0.18% per year. The fund size is €542 m. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Ireland.
- Launch date 20.09.2022 (4 years)
- Number of Holdings 83
- Strategy Passive (index tracking)
- Base Currency EUR
- Currency hedging No
- Distribution Policy Accumulating
- Replication Method Physical
- Securities lending Yes
- Domicile IE
- UCITS Compliant Yes
Price development
Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.
Risk figures (12 months)
No calculated risk figures are available for this fund yet.
The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.
Documents
We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.
Search documents at Amundi ETFTracking difference and tracking error
We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.
What does the fund invest in?
As of 09.09.2026 · Source: justETF / etfdbSector Breakdown
-
Health care 98.3%
-
Consumer staples 1.4%
-
Consumer discretionary 0.3%
Country Breakdown
-
United States 74.0%
-
Switzerland 9.7%
-
United Kingdom 5.4%
-
Denmark 2.7%
-
Japan 2.7%
-
Belgium 1.6%
-
France 1.5%
-
Australia 0.9%
-
Germany 0.4%
-
Sweden 0.3%
-
All others 0.8%
Holdings
Showing 10 holdings that together make up 54.6 % of fund assets. (out of 83 holdings in total).
| # | Name | ISIN | Sector | Country | Weight |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | US5324571083 | – | – | 12.41 % |
| 2 | AbbVie, Inc. | US00287Y1091 | – | – | 8.49 % |
| 3 | UnitedHealth Group Inc | US91324P1021 | – | – | 5.22 % |
| 4 | Merck & Co., Inc. | US58933Y1055 | – | – | 5.13 % |
| 5 | Novartis AG | CH0012005267 | – | – | 5.08 % |
| 6 | AstraZeneca PLC | GB0009895292 | – | – | 4.62 % |
| 7 | Roche Holding AG | CH1499059983 | – | – | 3.99 % |
| 8 | Amgen, Inc. | US0311621009 | – | – | 3.63 % |
| 9 | Gilead Sciences, Inc. | US3755581036 | – | – | 3.18 % |
| 10 | Thermo Fisher Scientific, Inc. | US8835561023 | – | – | 2.84 % |
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.
Alternatives on the same index
Other ETFs tracking the S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care – cheapest first.| Name | TER | Fund Volume | Distribution |
|---|---|---|---|
| Amundi S&P Global Health Care ESG UCITS ETF DR EUR (A) This fund | 0.18% | €542 m | Accumulating |
| Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) | 0.18% | €129 m | Distributing |
Frequently asked questions about the Amundi S&P Global Health Care ESG UCITS ETF DR EUR (A)
All information without guarantee. It is provided for information purposes only and does not constitute investment advice.